Literature DB >> 19821123

Structural basis for decreased affinity of Emodin binding to Val66-mutated human CK2 alpha as determined by molecular dynamics.

Na Zhang1, Rugang Zhong.   

Abstract

Protein kinase CK2 (casein kinase 2) is a multifunctional serine/threonine kinase that is involved in a broad range of physiological events. The decreased affinity of Emodin binding to human CK2 alpha resulting from single-point mutation of Val66 to Ala (V66A) has been demonstrated by experimental mutagenesis. Molecular dynamics (MD) simulations and energy analysis were performed on wild type (WT) and V66A mutant CK2 alpha-Emodin complexes to investigate the subtle influences of amino acid replacement on the structure of the complex. The structure of CK2 alpha and the orientation of Emodin undergo changes to different degrees in V66A mutant. The affected positions in CK2 alpha are mainly distributed over the glycine-rich loop (G-loop), the alpha-helix and the loop located at the portion between G-loop and alpha-helix (C-loop). Based on the coupling among these segments, an allosteric mechanism among the C-loop, the G-loop and the deviated Emodin is proposed. Additionally, an estimated energy calculation and residue-based energy decomposition also indicate the lower instability of V66A mutant in contrast to WT, as well as the unfavorable energetic influences on critical residue contributions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19821123     DOI: 10.1007/s00894-009-0582-2

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  40 in total

1.  GTP plus water mimic ATP in the active site of protein kinase CK2.

Authors:  K Niefind; M Pütter; B Guerra; O G Issinger; D Schomburg
Journal:  Nat Struct Biol       Date:  1999-12

2.  Inhibition of protein kinase CK2 by anthraquinone-related compounds. A structural insight.

Authors:  Erika De Moliner; Stefano Moro; Stefania Sarno; Giuseppe Zagotto; Giuseppe Zanotti; Lorenzo A Pinna; Roberto Battistutta
Journal:  J Biol Chem       Date:  2002-11-04       Impact factor: 5.157

3.  Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.

Authors:  M Mohammadi; G McMahon; L Sun; C Tang; P Hirth; B K Yeh; S R Hubbard; J Schlessinger
Journal:  Science       Date:  1997-05-09       Impact factor: 47.728

4.  Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes.

Authors:  Holger Gohlke; Christina Kiel; David A Case
Journal:  J Mol Biol       Date:  2003-07-18       Impact factor: 5.469

5.  A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.

Authors:  Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman
Journal:  J Comput Chem       Date:  2003-12       Impact factor: 3.376

Review 6.  Protein kinase CK2: a challenge to canons.

Authors:  Lorenzo A Pinna
Journal:  J Cell Sci       Date:  2002-10-15       Impact factor: 5.285

Review 7.  Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2.

Authors:  James S Duncan; David W Litchfield
Journal:  Biochim Biophys Acta       Date:  2007-08-30

8.  Kinetic analyses of mutations in the glycine-rich loop of cAMP-dependent protein kinase.

Authors:  B D Grant; W Hemmer; I Tsigelny; J A Adams; S S Taylor
Journal:  Biochemistry       Date:  1998-05-26       Impact factor: 3.162

9.  The selectivity of inhibitors of protein kinase CK2: an update.

Authors:  Mario A Pagano; Jenny Bain; Zygmunt Kazimierczuk; Stefania Sarno; Maria Ruzzene; Giovanni Di Maira; Matthew Elliott; Andrzej Orzeszko; Giorgio Cozza; Flavio Meggio; Lorenzo A Pinna
Journal:  Biochem J       Date:  2008-11-01       Impact factor: 3.857

Review 10.  A structural insight into CK2 inhibition.

Authors:  Marco Mazzorana; Lorenzo A Pinna; Roberto Battistutta
Journal:  Mol Cell Biochem       Date:  2008-07-15       Impact factor: 3.396

View more
  5 in total

Review 1.  Bioinformatics and variability in drug response: a protein structural perspective.

Authors:  Jennifer L Lahti; Grace W Tang; Emidio Capriotti; Tianyun Liu; Russ B Altman
Journal:  J R Soc Interface       Date:  2012-05-02       Impact factor: 4.118

2.  Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of EEF1D as a substrate for CK2.

Authors:  Laszlo Gyenis; James S Duncan; Jacob P Turowec; Maria Bretner; David W Litchfield
Journal:  J Proteome Res       Date:  2011-10-13       Impact factor: 4.466

3.  Insights into the Impact of Linker Flexibility and Fragment Ionization on the Design of CK2 Allosteric Inhibitors: Comparative Molecular Dynamics Simulation Studies.

Authors:  Yue Zhou; Na Zhang; Xiaoqian Qi; Shan Tang; Guohui Sun; Lijiao Zhao; Rugang Zhong; Yongzhen Peng
Journal:  Int J Mol Sci       Date:  2018-01-01       Impact factor: 5.923

4.  Exploring the Pivotal Role of the CK2 Hinge Region Sub-Pocket in Binding with Tricyclic Quinolone Analogues by Computational Analysis.

Authors:  Yue Zhou; Na Zhang; Shan Tang; Xiaoqian Qi; Lijiao Zhao; Rugang Zhong; Yongzhen Peng
Journal:  Molecules       Date:  2017-05-19       Impact factor: 4.411

5.  The protein kinase CK2 catalytic domain from Plasmodium falciparum: crystal structure, tyrosine kinase activity and inhibition.

Authors:  David Ruiz-Carrillo; Jianqing Lin; Abbas El Sahili; Meng Wei; Siu Kwan Sze; Peter C F Cheung; Christian Doerig; Julien Lescar
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.